Pipeline — registered trials by phase
Clinical Evaluation of the OEC Elite MD for Vascular Procedures at Hamilton General Hospital
— · Interventional Vascular Conditions · Completed · est. 2018-05-15
Comparison of Diagnostic Rest/Stress SPECT Results for Patients With Myocardial Ischemia and Infarction Using Myoview in Both Single and Dual Isotope Acquisition Approaches
— · Coronary Artery Disease · Completed
Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer
— · Metastatic Breast Cancer · Active Not Recruiting · est. 2025-04-18
Evaluation of the Goldcrest Patch Performance
— · Fetal Monitoring · Completed · est. 2025-03-31
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
— · Parkinson Disease, Parkinsonian Syndrome · Completed · est. 2006-12
A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms
— · Parkinsonian Syndromes · Completed · est. 2011-01
Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR).
— · Pulmonary Hypertension · Completed · est. 2010-07
NMT EasyFit Sensor and Cable
— · Neuromuscular Blockade Monitoring, NMT · Recruiting · est. 2026-10-31
Clinical Evaluation of a Dual Energy CT System
— · General CT Imaging · Completed · est. 2016-07
Maternal Fetal Device Performance Twins
— · Pregnancy · Completed · est. 2025-10-09
Accuracy Study of a Non-Invasive Blood Pressure Cuff in Comparison to an Invasive Radial Arterial Blood Pressure
— · Blood Pressure · Completed · est. 2011-12
Data Collection for Next Generation Ultrasound Technology Development
— · Endstage Renal Disease · Completed · est. 2016-12-06
Feasibility of a Deep Learning-based Algorithm for Non-invasive Assessment of Vulnerable Coronary Plaque
— · Chronic Coronary Syndrome, Coronary Artery Disease, Stable Angina · Not Yet Recruiting · est. 2025-06
Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Prospective Double-Scanning Study
— · SPECT-CT · Recruiting · est. 2027-02
Multi-site Anesthesia Randomized Controlled STudy of End Tidal Control Compared to Conventional Anesthesia Results
— · Et Control Performance in Adult Population Surgery · Completed · est. 2018-09-05
Comparison of 18F FDG PET/CT TO PET MRI
— · Any Condition With a Clinical Indication for PET/CT Exam · Completed · est. 2014-06
Wireless Disposable SpO2 Sensor Hypoxia Testing
— · SpO2, Peripheral Oxygen Saturation Measurement · Completed · est. 2024-02-08
NIBP Accuracy Study for Adult Subject Populations
— · Blood Pressure Measurement, Blood Pressure · Recruiting · est. 2026-12-31
Spectral CT With Advanced CT Technology
— · CT Photon-Counting · Completed · est. 2022-12-14
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
— · Breast Cancer · Recruiting · est. 2027-07-31
Portrait Mobile Monitoring Solution V2.0 External Evaluation
— · Monitoring · Not Yet Recruiting · est. 2026-10
Non-Invasive Blood Pressure Accuracy Study for Adult Subject Populations
— · Blood Pressure, Blood Pressure Measurement · Recruiting · est. 2026-12-31
Post-Marketing Safety Study in ST-Segment Elevation Myocardial Infarction (STEMI) Participants Undergoing Primary Percutaneous Coronary Intervention (PCI) Procedure With VISIPAQUE® as the Contrast Medium
— · Coronary Artery Disease, ST-segment Elevation Myocardial Infarction · Completed · est. 2021-06-07
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
— · Breast Cancer, Brain Metastases · Recruiting · est. 2027-12
Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver Imaging
— · Focal Liver Lesions · Recruiting · est. 2026-07-31
A Study to Evaluate the Safety, Biodistribution, Internal Radiation Dosimetry, and Effective Dose of DaTSCAN™ Ioflupane (123I) Injection in Chinese Healthy Volunteers.
— · Healthy Subjects (HS) · Completed · est. 2021-09-04
A Study to Evaluate Pharmacokinetics of Sonazoid™ Following Intravenous Bolus Injection in Healthy Volunteers
— · Healthy · Completed · est. 2014-11-20
Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers
— · Alzheimer's Disease, Amnestic Mild Cognitive Impairment · Completed · est. 2009-03
Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure
— · Chronic Renal Insufficiency, Diabete Mellitus, Congestive Heart Failure · Completed · est. 2012-12
A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
— · Myocardial Ischemia, Coronary Artery Disease · Recruiting · est. 2026-12
A Study of Flurpiridaz (18F) Injection for PET Imaging for Assessment of MPI Quality Using HPLC and SPE Manufacturing Processes
— · Coronary Artery Disease (CAD), Ischemic Heart Disease · Completed · est. 2022-05-26
Evaluation of Computer-assisted, Non-cathartic CT Colonography
— · Colonic Polyps · Completed · est. 2010-10
A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-iliac Arteries While Using Gadodiamide
— · Aorto-iliac Stenosis, Arterial Occlusive Diseases · Completed · est. 2006-02-28
A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients
— · Known or Highly Suspected Central Nervous System (CNS) Lesion, Known or Highly Suspected Body (Excluding CNS) Lesion · Recruiting · est. 2027-11-30
PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus
— · Normal Pressure Hydrocephalus · Completed · est. 2010-07
An Efficacy and Safety Study of Sonazoid™ and SonoVue® in Participants With Focal Liver Lesions, Undergoing Pre- and Post-Contrast Ultrasound Imaging
— · Liver Lesions · Completed · est. 2015-04-09
Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) Images
— · Alzheimer's Disease, Mild Cognitive Impairment · Completed · est. 2012-08
[18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor
— · Parkinson Disease, Essential Tremor · Completed · est. 2024-08-02
Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease
— · Mild Cognitive Impairment, Alzheimer's Disease · Completed · est. 2014-01
A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients
— · Parkinsonian Syndrome, Parkinson Disease(PD), Multiple System Atrophy (MSA) · Completed · est. 2021-12-20
AdreviewIobenguane Sulfate I-123
CeretecTechnetium Tc-99M Exametazime Kit
CeriannaFluoroestradiol F-18
ClariscanGadoterate Meglumine
Indium In 111 OxyquinolineIndium In-111 Oxyquinoline
Mpi Indium Dtpa In 111Indium In-111 Pentetate Disodium
Omnipaque 12Iohexol
Omnipaque 140Iohexol
Omnipaque 180Iohexol
Omnipaque 240Iohexol
Omnipaque 300Iohexol
Omnipaque 350Iohexol
Omnipaque 9Iohexol
OmniscanGadodiamide
OptisonAlbumin Human
Visipaque 270Iodixanol
Visipaque 320Iodixanol
VizamylFlutemetamol F-18
Source: ClinicalTrials.gov (trials where GE HealthCare is lead sponsor; 49 active or completed) and Drugs@FDA (18 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-09-22Current report (material event)
- 8-K2026-08-18Current report (material event)
- SCHEDULE 13G/A2026-08-07SCHEDULE 13G/A
- SCHEDULE 13G/A2026-08-07SCHEDULE 13G/A
- 8-K2026-07-29Current report (material event)
- 10-Q2026-07-29Quarterly report
- 8-K2026-07-29Current report (material event)
- 8-K2026-07-23Current report (material event)
- SD2026-05-29SD
- SCHEDULE 13G/A2026-05-14SCHEDULE 13G/A
- SCHEDULE 13G/A2026-05-14SCHEDULE 13G/A
- 8-K2026-05-11Current report (material event)
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- 10-Q2026-04-29Quarterly report
- 8-K2026-04-29Current report (material event)
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- ARS2026-03-19Annual report to holders
- DEFA14A2026-03-19DEFA14A
- DEF 14A2026-03-19Proxy statement
- 8-K2026-03-17Current report (material event)
- 8-K2026-02-27Current report (material event)
- SCHEDULE 13G/A2026-02-13SCHEDULE 13G/A
- 10-K2026-02-04Annual report
- 8-K2026-02-04Current report (material event)
- 8-K2025-12-15Current report (material event)
- 424B22025-12-02424B2
- 8-K2025-12-02Current report (material event)
- FWP2025-12-01FWP
- 424B22025-12-01424B2
- SCHEDULE 13G2025-11-13SCHEDULE 13G
- 10-Q2025-10-29Quarterly report
- 8-K2025-10-29Current report (material event)
- SCHEDULE 13G2025-08-13SCHEDULE 13G
- 10-Q2025-07-30Quarterly report
- 8-K2025-07-30Current report (material event)
- 8-K2025-07-24Current report (material event)
- 8-K2025-06-09Current report (material event)
- SCHEDULE 13G/A2025-06-06SCHEDULE 13G/A
- 424B22025-06-05424B2
- 8-K2025-06-04Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.